Experiment: 1WCO

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	1H-15N CT HSQC	100% D6-DMSO				1.0 atm	300.0
2	31P 1D	100% D6-DMSO				1.0 atm	300.0
3	1H-13C HSQC	100% D6-DMSO				1.0 atm	300.0
4	1H-13C HMBC	100% D6-DMSO				1.0 atm	300.0
5	31P 1D	100% D6-DMSO				1.0 atm	300.0
6	1H-15N-NOESY HSQC	100% D6-DMSO				1.0 atm	300.0
7	1H-1H NOESY	100% D6-DMSO				1.0 atm	300.0
8	1H-15N TOCSY- HSQC	100% D6-DMSO				1.0 atm	300.0
9	1H-1H TOCSY	100% D6-DMSO				1.0 atm	300.0
10	1H-1H COSY	100% D6-DMSO				1.0 atm	300.0
11	1H-15N-NOESY HSQC	100% D6-DMSO				1.0 atm	300.0
12	1H-1H NOESY	100% D6-DMSO				1.0 atm	300.0

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	500
2	Bruker	AVANCE	600
3	Bruker	AVANCE	750
4	Bruker	AVANCE	900

NMR Refinement
Method	Details	Software
HADDOCK	REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE. THE ENSEMBLE OF STRUCTURES IS SUPERIMPOSED ON THE CA OF NISIN RESIDUES 1-12 (CHAIN N), THE HEAVY ATOMS OF MURNAC, PYROPHOSPHATE AND THE FIRST ISOPRENE OF 3-LIPID II (CHAIN L) AS THESE ARE THE ONLY SEGMENTS THAT HAVE SUFFICIENT DISTANCE RESTRAINTS TO DEFINE THE COMPLEX STRUCTURE. OTHER RESIDUES NAMELY RESIDUES 13-34 (ESPECIALLY RESIDUES 20-34) OF NISIN, THE PENTAPEPTIDE AND TERMINAL ISOPRENE UNITS OF 3-LIPID II ARE FLEXIBLE AS SUPPORTED BY DYNAMICS DATA. THE ATOM OCCUPANCY OF THE C- TERMINAL TAIL OF NISIN (RESIDUES 20-34) HAS BEEN MODIFIED TO BE 0.3 TO REFLECT THEIR DISORDER/FLEXIBILITY.	CNS

NMR Ensemble Information
Conformer Selection Criteria	RMSD CLUSTERING AND LOWEST TOTAL ENERGY
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20

Additional NMR Experimental Information
Details	THE STRUCTURE WAS DETERMINED USING MULTIDIMENSIONAL NMR SPECTROSCOPY ON 15N-LABELLED NISIN IN COMPLEX WITH UNLABELLED 3-LIPID II. INTERMOLECULAR HYDROGEN BONDS WERE IDENTIFIED AND USED IN STRUCTURAL CALCULATION BY 31P- EDITED 1H-15N CT HSQC.

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CNS	1.1	BRUNGER,ADAMS,CLORE,DELANO,GROS, GROSSE- KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU,READ, RICE,SIMONSON,WARREN
2	structure solution	NMRView	VIEW
3	structure solution	CNS

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.